Boston Scientific says cyberattack likely to hurt 2026 sales, profit

Boston Scientific said a cybersecurity incident has disrupted manufacturing and global order shipments and is likely to materially affect its Q3 and full-year 2026 financial results. The operational disruption creates near-term revenue, supply-chain and earnings risk for the medical-device maker.